Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RVNC crawled time : 18:00 save search
Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results
Published: 2022-09-08 (Crawled : 18:00) - biospace.com/
VTRS | $11.23 0.99% 1.5M
|
Health Technology
|
| O: -0.57%
H: 0.83%
C: 0.16%
RVNC | $3.76 -0.79% 570K
|
Health Technology
|
| O: 18.79%
H: 3.03%
C: 2.35%
fda approval
Revance Issues Inaugural Environmental, Social and Governance (ESG) Report
Published: 2021-01-22 (Crawled : 18:00) - biospace.com/
RVNC | $3.76 -0.79% 570K
|
Health Technology
|
| O: -1.2%
H: 2.78%
C: 1.93%
ev
Revance Provides Corporate Update and Anticipated Milestones for 2021
Published: 2021-01-07 (Crawled : 18:00) - biospace.com/
RVNC | $3.76 -0.79% 570K
|
Health Technology
|
| O: 0.66%
H: 9.0%
C: 8.07%
milestone
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.